|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/42 | |
| C07K 16/10 | |||
| A61P 31/16 |
| (11) | Number of the document | 2919813 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13854201.4 |
| Date of filing the European patent application | 2013-11-12 | |
| (97) | Date of publication of the European application | 2015-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/069567 |
| Date | 2013-11-12 |
| (87) | Number | WO 2014/078268 |
| Date | 2014-05-22 |
| (30) | Number | Date | Country code |
| 201261725859 P | 2012-11-13 | US |
| (72) |
XU, Min, US
BALAZS, Mercedesz, US
CHAI, Ning, US
CHIANG, Nancy, US
CHIU, Henry, US
JIN, Zhaoyu, US
LIN, Zhonghua, US
LUPARDUS, Patrick, J., US
NAKAMURA, Gerald, R., US
PARK, Hyunjoo, US
SWEM, Lee, R., US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | ANTI-HEMAGGLUTININ ANTIBODIES AND METHODS OF USE |
| ANTI-HEMAGGLUTININ ANTIBODIES AND METHODS OF USE |